- Home
- LCFY vs SLXN Comparison
LCFY vs SLXN Comparison
Compare LCFY & SLXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCFY
- SLXN
- Stock Information
- Founded
- LCFY 2009
- SLXN 2008
- Country
- LCFY Australia
- SLXN Israel
- Employees
- LCFY N/A
- SLXN N/A
- Industry
- LCFY
- SLXN
- Sector
- LCFY
- SLXN
- Exchange
- LCFY Nasdaq
- SLXN NYSE
- Market Cap
- LCFY 9.9M
- SLXN 4.3M
- IPO Year
- LCFY 2022
- SLXN N/A
- Fundamental
- Price
- LCFY $6.04
- SLXN $1.26
- Analyst Decision
- LCFY
- SLXN Strong Buy
- Analyst Count
- LCFY 0
- SLXN 1
- Target Price
- LCFY N/A
- SLXN $9.00
- AVG Volume (30 Days)
- LCFY 12.4K
- SLXN 9.6M
- Earning Date
- LCFY 04-30-2025
- SLXN 03-18-2025
- Dividend Yield
- LCFY N/A
- SLXN N/A
- EPS Growth
- LCFY N/A
- SLXN N/A
- EPS
- LCFY N/A
- SLXN N/A
- Revenue
- LCFY $2,668,385.00
- SLXN N/A
- Revenue This Year
- LCFY N/A
- SLXN N/A
- Revenue Next Year
- LCFY N/A
- SLXN N/A
- P/E Ratio
- LCFY N/A
- SLXN N/A
- Revenue Growth
- LCFY N/A
- SLXN N/A
- 52 Week Low
- LCFY $2.20
- SLXN $0.21
- 52 Week High
- LCFY $11.23
- SLXN $13.56
- Technical
- Relative Strength Index (RSI)
- LCFY 38.25
- SLXN N/A
- Support Level
- LCFY $5.08
- SLXN N/A
- Resistance Level
- LCFY $8.80
- SLXN N/A
- Average True Range (ATR)
- LCFY 0.52
- SLXN 0.00
- MACD
- LCFY -0.11
- SLXN 0.00
- Stochastic Oscillator
- LCFY 25.89
- SLXN 0.00
About LCFY Locafy Limited
Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.
About SLXN BIOMOTION SCIENCES
Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.